COST-EFFECTIVENESS OF CANNABIDIOL (CBD) FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH TREATMENT-RESISTANT LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME IN THE NETHERLANDS

被引：0
|
作者：
Siddiqui, J. [1 ]
Bowditch, S. [2 ]
机构：
[1] FIECON Ltd, London, England
[2] Jazz Pharmaceut, London, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE400
引用
收藏
页码：S127 / S128
页数：2
相关论文
共 50 条
  • [31] Value of cannabidiol as adjunctive treatment for Lennox Gastaut syndrome: cost-effectiveness and budget impact analysis
    Goudarzi, Zahra
    Lotfi, Farhad
    Shahtaheri, Rahil sadat
    Moradi, Nasrin
    Taghizadeh, Mohsen
    Keshavarz, Khosro
    BMC MEDICINE, 2025, 23 (01):
  • [32] Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome
    Lattanzi, Simona
    Zaccara, Gaetano
    Russo, Emilio
    La Neve, Angela
    Lodi, Monica Anna Maria
    Striano, Pasquale
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (01) : 99 - 110
  • [33] Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome
    Lattanzi, Simona
    Trinka, Eugen
    Striano, Pasquale
    Rocchi, Chiara
    Salvemini, Sergio
    Silvestrini, Mauro
    Brigo, Francesco
    CNS DRUGS, 2021, 35 (03) : 265 - 281
  • [34] Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
    Ostendorf, Adam P.
    Ng, Yu-Tze
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 1131 - 1140
  • [35] Caregivers' Perspectives on the Impact of Cannabidiol (CBD) Treatment for Dravet and Lennox-Gastaut Syndromes: A Multinational Qualitative Study
    Marshall, Jade
    Skrobanski, Hanna
    Moore-Ramdin, Lisa
    Kornalska, Klaudia
    Swinburn, Paul
    Bowditch, Sally
    JOURNAL OF CHILD NEUROLOGY, 2023, : 394 - 406
  • [36] Diarrhoea in patients with Lennox-Gastaut Syndrome (LGS) or Dravet Syndrome (DS) enrolled in four phase 3 Clinical Trials of Cannabidiol (CBD)
    Nabbout, Rima
    Bhathal, Hari
    Zolnowska, Marta
    Sidhu, Meneka
    Li, Jie
    Hyland, Kerry
    Nortvedt, Charlotte
    EPILEPSIA, 2021, 62 : 273 - 274
  • [37] Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome
    Iannone, Luigi Francesco
    Arena, Gabriele
    Battaglia, Domenica
    Bisulli, Francesca
    Bonanni, Paolo
    Boni, Antonella
    Canevini, Maria Paola
    Cantalupo, Gaetano
    Cesaroni, Elisabetta
    Contin, Manuela
    Coppola, Antonietta
    Cordelli, Duccio Maria
    Cricchiuti, Giovanni
    De Giorgis, Valentina
    De Leva, Maria Fulvia
    De Rinaldis, Marta
    d'Orsi, Giuseppe
    Elia, Maurizio
    Galimberti, Carlo Andrea
    Morano, Alessandra
    Granata, Tiziana
    Guerrini, Renzo
    Lodi, Monica A. M.
    La Neve, Angela
    Marchese, Francesca
    Masnada, Silvia
    Michelucci, Roberto
    Nosadini, Margherita
    Pilolli, Nicola
    Pruna, Dario
    Ragona, Francesca
    Rosati, Anna
    Santucci, Margherita
    Spalice, Alberto
    Pietrafusa, Nicola
    Striano, Pasquale
    Tartara, Elena
    Tassi, Laura
    Papa, Amanda
    Zucca, Claudio
    Russo, Emilio
    Mecarelli, Oriano
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [38] Fenfluramine for the Treatment of Dravet Syndrome and Lennox–Gastaut Syndrome
    Ganna Balagura
    Marta Cacciatore
    Eleonora A. Grasso
    Pasquale Striano
    Alberto Verrotti
    CNS Drugs, 2020, 34 : 1001 - 1007
  • [39] Levetiracetam in the treatment of Lennox-Gastaut syndrome
    de los Reyes, EC
    Sharp, GB
    Hale, SE
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S108 - S108
  • [40] Clobazam in the treatment of lennox-gastaut syndrome
    Conry, Joan A.
    Paolicchi, Juliann
    Stolle, Julie C.
    Johnson, Ashira
    Collins, Stephen D.
    EPILEPSIA, 2006, 47 : 178 - 179
12345